BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22998478)

  • 1. Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.
    Rangel A; Race B; Striebel J; Chesebro B
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):217-30. PubMed ID: 22998478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein.
    Rangel A; Race B; Klingeborn M; Striebel J; Chesebro B
    Acta Neuropathol Commun; 2013 Jun; 1():25. PubMed ID: 24252347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein.
    Rangel A; Race B; Phillips K; Striebel J; Kurtz N; Chesebro B
    Acta Neuropathol Commun; 2014 Jan; 2():8. PubMed ID: 24447368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
    Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
    PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.
    Race B; Jeffrey M; McGovern G; Dorward D; Chesebro B
    Prion; 2017 Jul; 11(4):234-248. PubMed ID: 28759310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.
    Race B; Phillips K; Meade-White K; Striebel J; Chesebro B
    J Virol; 2015 Jun; 89(11):6022-32. PubMed ID: 25810548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-associated cerebral amyloid angiopathy is not exacerbated by human phosphorylated tau aggregates in scrapie-infected mice expressing anchorless prion protein.
    Race B; Williams K; Striebel JF; Chesebro B
    Neurobiol Dis; 2020 Oct; 144():105057. PubMed ID: 32829029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Meade-White K; Barbieri I; Brocchi E; Ghetti B; Monaco S
    J Biol Chem; 2014 Feb; 289(8):4870-81. PubMed ID: 24398683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
    Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
    Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.
    Race B; Phillips K; Kraus A; Chesebro B
    Prion; 2016 Jul; 10(4):319-30. PubMed ID: 27463540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC.
    Vascellari S; Orrù CD; Hughson AG; King D; Barron R; Wilham JM; Baron GS; Race B; Pani A; Caughey B
    PLoS One; 2012; 7(11):e48969. PubMed ID: 23139828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.
    Klingeborn M; Race B; Meade-White KD; Rosenke R; Striebel JF; Chesebro B
    J Virol; 2011 Feb; 85(4):1484-94. PubMed ID: 21123371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.
    Kovacs GG; Makarava N; Savtchenko R; Baskakov IV
    Am J Pathol; 2013 Nov; 183(5):1539-1547. PubMed ID: 24012784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.
    Peden AH; Sarode DP; Mulholland CR; Barria MA; Ritchie DL; Ironside JW; Head MW
    Acta Neuropathol Commun; 2014 Oct; 2():152. PubMed ID: 25331173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards authentic transgenic mouse models of heritable PrP prion diseases.
    Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
    Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.
    Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA
    BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting prion amyloid deposits in vivo.
    Sadowski M; Pankiewicz J; Scholtzova H; Tsai J; Li Y; Carp RI; Meeker HC; Gambetti P; Debnath M; Mathis CA; Shao L; Gan WB; Klunk WE; Wisniewski T
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):775-84. PubMed ID: 15290902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two alternative pathways for generating transmissible prion disease de novo.
    Makarava N; Savtchenko R; Baskakov IV
    Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.